MTI News spoke to Kathleen Orland, senior vice president and general manager for Beckman Coulter’s clinical chemistry immunoassay about the key role of Access hsTnI assay to detect at-risk patients earlier and discharge non-acute patients faster.
Show CommentsClose Comments